Patents by Inventor Soheila Anzali

Soheila Anzali has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10278911
    Abstract: The invention relates generally to cyclic peptides and their use in compositions, especially topical, cosmetic and/or personal care compositions, and compositions containing said cyclic peptides.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: May 7, 2019
    Assignee: MERCK PATENT GMBH
    Inventors: Soheila Anzali, Alfred Jonczyk
  • Patent number: 9700501
    Abstract: The invention relates to a compound of formula I wherein R1, R2 and R3 are identical or different and each is H or alkyl of 1-6 carbon atoms, R4 is H or methyl, R5 is phenyl or chlorophenyl, and/or physiologically acceptable salts thereof and its use in compositions, especially topical, cosmetic and/or personal care compositions, and compositions containing said compound.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: July 11, 2017
    Assignee: Merck Patent GmbH
    Inventors: Soheila Anzali, Francis Contard, Jean Jacques Zeiller
  • Publication number: 20150265516
    Abstract: The invention relates generally to cyclic peptides and their use in compositions, especially topical, cosmetic and/or personal care compositions, and compositions containing said cyclic peptides.
    Type: Application
    Filed: May 11, 2015
    Publication date: September 24, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Soheila ANZALI, Alfred JONCZYK
  • Publication number: 20140017187
    Abstract: The invention relates to 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl-penta-2,4-dienoic acid and its use in compositions, especially topical, cosmetic and/or personal care compositions, and compositions containing said compound.
    Type: Application
    Filed: July 1, 2013
    Publication date: January 16, 2014
    Applicant: Merck Patent GmbH
    Inventors: Soheila ANZALI, Francis Contard, Jean Jacques Zeiller
  • Publication number: 20110144130
    Abstract: The invention relates to 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl-penta-2,4-dienoic acid and its use in compositions, especially topical, cosmetic and/or personal care compositions, and compositions containing said compound.
    Type: Application
    Filed: July 27, 2009
    Publication date: June 16, 2011
    Applicant: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
    Inventors: Soheila Anzali, Francis Contard, Jean Jacques Zeiller
  • Publication number: 20110142777
    Abstract: The invention relates to a compound of formula I wherein R1, R2 and R3 are identical or different and each is H or alkyl of 1-6 carbon atoms, R4 is H or methyl, R5 is phenyl or chlorophenyl, and/or physiologically acceptable salts thereof and its use in compositions, especially topical, cosmetic and/or personal care compositions, and compositions containing said compound.
    Type: Application
    Filed: July 30, 2009
    Publication date: June 16, 2011
    Inventors: Soheila Anzali, Francis Contard, Jean Jacques Zeiller
  • Patent number: 7914893
    Abstract: Disclosed are particles containing substrates and an anion-binding layer, containing one or more anion-forming organic active compounds or active compound/colorant mixtures; processes for preparing said particles and to methods of use thereof in cosmetics, pharmaceuticals, formulations, paints, coatings, plastics, films, in security printing, in security features in documents or identity papers, for coloring seed, for coloring foods or in medicament coatings and for the preparation of pigment compositions and dry preparations.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: March 29, 2011
    Assignee: Merck Patent GmbH
    Inventors: Carsten Handrosch, Thomas Rudolph, Herwig Buchholz, Soheila Anzali
  • Publication number: 20110027209
    Abstract: The invention relates generally to cyclic peptides and their use in compositions, especially topical, cosmetic and/or personal care compositions, and compositions containing said cyclic peptides.
    Type: Application
    Filed: April 8, 2009
    Publication date: February 3, 2011
    Applicant: MERCK PATENT GESELLSCHAFT
    Inventors: Soheila Anzali, Alfred Jonczyk
  • Publication number: 20070275244
    Abstract: Disclosed are particles containing substrates and an anion-binding layer, containing one or more anion-forming organic active compounds or active compound/colorant mixtures; processes for preparing said particles and to methods of use thereof in cosmetics, pharmaceuticals, formulations, paints, coatings, plastics, films, in security printing, in security features in documents or identity papers, for coloring seed, for coloring foods or in medicament coatings and for the preparation of pigment compositions and dry preparations.
    Type: Application
    Filed: May 24, 2007
    Publication date: November 29, 2007
    Inventors: Carsten Handrosch, Thomas Rudolph, Herwig Buchholz, Soheila Anzali
  • Publication number: 20070219246
    Abstract: Compounds of the formula (I) in which W, R1, R2, R3, R4, and q have the meanings indicated in Claim 1, can be employed, inter alia, for the treatment of tumours.
    Type: Application
    Filed: April 28, 2005
    Publication date: September 20, 2007
    Inventors: Dirk Finsinger, Soheila Anzali, Matthias Frech, Johannes Gleitz, Nina Heiss, Bjoern Hock, Kai Schiemann, Frank Zenke
  • Publication number: 20070191353
    Abstract: Use of compounds of the formula (I), in which Ar1, Ar2 and Z have the meanings indicated in Patent Claim 1, for the prophylaxis and/or treatment of diseases in which the inhibition, regulation and/or modulation of signal transduction by kinases, in particular RAF kinases, plays a role.
    Type: Application
    Filed: January 31, 2005
    Publication date: August 16, 2007
    Inventors: Lars Burgdorf, Frank Stieber, Hans-Peter Buchstaller, Soheila Anzali, Christiane Amendt, Hartmut Greiner, Matthias Grell, Christian Sirrenberg, Frank Zenke
  • Publication number: 20040093170
    Abstract: The present invention relates to a method for determining pharmaceutically active substances with the aid of test series, in which the action of a large number of different substances on one or more biological targets is tested and a hit list of those substances which actually or apparently have shown a pharmaceutical action on at least one biological target is prepared, whereupon a selection is made from the hits for more detailed investigations of pharmaceutical activity and/or applicability.
    Type: Application
    Filed: August 19, 2003
    Publication date: May 13, 2004
    Inventors: Soheila Anzali, Gerhard Barnickel, Bertram Cezanne, Michael Krug, Joachim Marz
  • Patent number: 6492384
    Abstract: The invention relates to novel compounds of formula (I), wherein R, R1, R2, R3, n and p have the meaning defined in claim 1. Compounds are inhibitors of clotting factor Xa and can be used for the prophylaxis and/or therapy of thrombo-embolic disorders.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: December 10, 2002
    Assignee: Merck Patent GmbH
    Inventors: Werner Mederski, Horst Juraszyk, Hanns Wurziger, Joachim Gante, Dieter Dorsch, Hans-Peter Buchstaller, Sabine Bernotat-Danielowski, Guido Melzer, Soheila Anzali
  • Patent number: 6017939
    Abstract: The invention concerns compounds of formula (I),in which R is (i), (ii) or (iii); n is 0, 1 or 2; X means O or S; and R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have different meanings, or a cyclized tautomeric shape. The invention also concerns the (E) isomers and salts of these compounds which display endothelin receptor antagonistic properties.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: January 25, 2000
    Assignee: Merck Patent Gesellschaft
    Inventors: Dieter Dorsch, Mathias Osswald, Werner Mederski, Claudia Wilm, Claus Schmitges, Maria Christadler, Soheila Anzali